<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="research-article">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">WASJ</journal-id>
<journal-title-group>
<journal-title>World Academy of Sciences Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">2632-2900</issn>
<issn pub-type="epub">2632-2919</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">WASJ-7-3-00324</article-id>
<article-id pub-id-type="doi">10.3892/wasj.2025.324</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Efficacy of <italic>Rhamnus frangula</italic> extract against <italic>Acinetobacter baumannii</italic> biofilms: Histopathological evidence from <italic>ex vivo</italic> goat models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Rony Varughese</surname><given-names>Riya Mariam</given-names></name>
<xref rid="af1-WASJ-7-3-00324" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pathoor</surname><given-names>Naji Naseef</given-names></name>
<xref rid="af2-WASJ-7-3-00324" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ranganathan</surname><given-names>Priyadharshini</given-names></name>
<xref rid="af3-WASJ-7-3-00324" ref-type="aff">3</xref>
<xref rid="c1-WASJ-7-3-00324" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ganesh</surname><given-names>Pitchaipillai Sankar</given-names></name>
<xref rid="af2-WASJ-7-3-00324" ref-type="aff">2</xref>
</contrib>
</contrib-group>
<aff id="af1-WASJ-7-3-00324"><label>1</label>Department of Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu 600 077, India</aff>
<aff id="af2-WASJ-7-3-00324"><label>2</label>Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu 600 077, India</aff>
<aff id="af3-WASJ-7-3-00324"><label>3</label>Department of Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu 600 077, India</aff>
<author-notes>
<corresp id="c1-WASJ-7-3-00324"><italic>Correspondence to:</italic> Dr Priyadharshini Ranganathan, Department of Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, 162 Poonamallee High Road, Chennai, Tamil Nadu 600 077, India <email>nishida@phar.kindai.ac.jp priyadharshinir328@gmail.com </email></corresp>
</author-notes>
<pub-date pub-type="collection">
<season>May-Jun</season>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>02</month>
<year>2025</year></pub-date>
<volume>7</volume>
<issue>3</issue>
<elocation-id>36</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>02</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2025 Rony Varughese et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
<abstract>
<p><italic>Acinetobacter baumannii</italic> (<italic>A. baumannii</italic>) is a Gram-negative pathogen notorious for causing severe nosocomial infections, largely due to its ability to form biofilms that enhance antibiotic resistance and complicate treatment strategies. The present study explored the therapeutic potential of <italic>Rhamnus frangula</italic> (<italic>R. frangula</italic>) extract in mitigating <italic>A. baumannii</italic>-induced biofilm formation and related organ damage in goat tissue samples. The efficacy of the extract was assessed using minimum inhibitory concentration (MIC) tests, histopathological evaluations of heart, lung, liver, kidney and spleen tissues, biofilm inhibition assays, and growth curve analysis. The MIC assay demonstrated that <italic>R. frangula</italic> extract effectively inhibited <italic>A. baumannii</italic> growth at a concentration of 5 mg/ml. Histopathological analysis revealed significant reductions in bacterial load and inflammatory infiltrates across all examined organs, with notable improvements, such as decreased myofibril disintegration in cardiac tissue and reduced alveolar damage in lung tissue. Furthermore, at a sub-MIC of 2.5 mg/ml, <italic>R. frangula</italic> extract reduced biofilm formation by 67.26%, while exhibiting no effect on planktonic bacterial growth, highlighting its specific antibiofilm activity. These findings underscore the potential of <italic>R. frangula</italic> extract as a promising natural therapeutic agent for the treatment of biofilm-associated infections and mitigating tissue damage caused by <italic>A. baumannii</italic>. However, further investigations into its molecular mechanisms and potential clinical applications are warranted to address the escalating challenge of antibiotic resistance and improve infection management strategies.</p>
</abstract>
<kwd-group>
<kwd><italic>Acinetobacter baumannii</italic></kwd>
<kwd>biofilm</kwd>
<kwd><italic>Rhamnus frangula</italic></kwd>
<kwd>histopathology</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p><italic>Acinetobacter baumannii</italic> (<italic>A. baumannii</italic>), is one of the most potentially hazardous bacteria in the domain of infections linked to healthcare. Once considered to be a generally benign environmental microbe, this Gram-negative coccobacillus has rapidly emerged as a major contributor to nosocomial infections worldwide (<xref rid="b1-WASJ-7-3-00324" ref-type="bibr">1</xref>). <italic>A. baumannii</italic> poses significant clinical challenges by driving persistent infections and organ damage, such as endocarditis and pneumonia, particualrly in immunocompromised individuals (<xref rid="b2-WASJ-7-3-00324" ref-type="bibr">2</xref>). Infections caused by <italic>A. baumannii</italic>, are of significant concern due to their ability to invade and damage vital organs, such as the lungs, liver, kidneys and spleen (<xref rid="b3-WASJ-7-3-00324" ref-type="bibr">3</xref>). <italic>A baumannii</italic> is a pathogen of key concern due to its ability to cause severe infections, particularly in immunocompromised individuals (<xref rid="b4-WASJ-7-3-00324" ref-type="bibr">4</xref>).</p>
<p>Biofilm formation by <italic>A. baumannii</italic> poses significant challenges in clinical settings, as it facilitates bacterial adhesion to surfaces, such as heart valves and lung tissue, resulting in persistent and difficult-to-treat infections (<xref rid="b5-WASJ-7-3-00324" ref-type="bibr">5</xref>,<xref rid="b6-WASJ-7-3-00324" ref-type="bibr">6</xref>). The biofilm matrix serves as a protective barrier, shielding bacteria from the host immune response and antibiotic treatment. In the heart, this can lead to endocarditis, marked by inflammation, tissue necrosis and the development of lesions or abscesses on the heart valves (<xref rid="b7-WASJ-7-3-00324" ref-type="bibr">7</xref>). The role of biofilm is pivotal in these processes, as it fosters the chronicity of the infection and complicates pathogen eradication. Similarly, in the lungs, <italic>A. baumannii</italic> biofilms can aggravate pulmonary infections, leading to conditions such as bronchitis, pneumonia and pleuritis. The dense bacterial communities within biofilms are linked to severe pathological changes, including lung tissue consolidation and, in extreme cases, abscess formation (<xref rid="b8-WASJ-7-3-00324" ref-type="bibr">8</xref>). These biofilm-related infections often present with respiratory distress, coughing and fever, similar to other bacterial infections, although with heightened resistance to treatment due to the protective nature of the biofilm (<xref rid="b9-WASJ-7-3-00324" ref-type="bibr">9</xref>). The ability of <italic>A. baumannii</italic> to form biofilms is closely linked to its virulence factors, which enable it to evade the immune system and persist within the host. The severity of infection, including the extent of tissue damage and clinical outcomes, is influenced by factors, such as the virulence of the strain, the bacterial load and the immune status of the host. Understanding the role of biofilm formation in <italic>A. baumannii</italic> infections is essential for devising more effective treatment strategies, particularly for overcoming the challenges posed by its antibiotic resistance (<xref rid="b1-WASJ-7-3-00324" ref-type="bibr">1</xref>). The interplay between biofilm formation and antibiotic resistance is crucial for understanding the pathogenesis of <italic>A</italic>. <italic>baumannii</italic> infections. Biofilms confer increased resistance to conventional treatments, making it difficult for antibiotics to penetrate and effectively kill the bacterial cells (<xref rid="b9-WASJ-7-3-00324" ref-type="bibr">9</xref>). Consequently, there is an urgent need for alternative therapeutic strategies that target both the bacterial cells and their biofilm structures.</p>
<p>Research reveals a strong positive association between biofilm formation and increased antibiotic resistance in <italic>A. baumannii</italic>. Strains of <italic>A. baumannii</italic> exhibit high resistance rates to ciprofloxacin, piperacillin and ceftazidime, with the blaOXA-23-like gene detected in 93% of multidrug-resistant (MDR) isolates (<xref rid="b10-WASJ-7-3-00324" ref-type="bibr">10</xref>). Additionally, 50 isolates have been identified as carbapenemase producers. Polymerase chain reaction (PCR) analysis has further demonstrated the presence of key virulence genes: traT (80%) associated with serum resistance, cvaC (34%) linked to colicin V production, and iutA (16%) involved in aerobactin synthesis (<xref rid="b11-WASJ-7-3-00324" ref-type="bibr">11</xref>). These findings underscore the critical association between biofilm formation and MDR in <italic>A. baumannii</italic>, highlighting the need for innovative approaches to combat infections caused by this resilient pathogen.</p>
<p>Natural medicine offers a promising and effective treatment option, potentially overcoming these challenges, while providing safer solutions for managing infections. Plants are extensively utilized in traditional medicine across the globe, as plant-derived treatments are considered relatively safe and provide more dependable and effective results. Compared to modern and conventional medicines, plant-based remedies have been reported to have fewer side-effects due to their natural origin (<xref rid="b12-WASJ-7-3-00324" ref-type="bibr">12</xref>). Plants produce secondary metabolites and phyto-constituents, including alkaloids, flavonoids, phenols, saponins, sterols, tannins and terpenoids, which can be used therapeutically in plants, humans and animals (<xref rid="b13-WASJ-7-3-00324" ref-type="bibr">13</xref>). <italic>Rhamnus frangula (R. frangula)</italic>, frequently referred to as glossy buckthorn or alder buckthorn, is a small tree or deciduous shrub that is a member of the <italic>Rhamnaceae</italic> family. It is currently found in North America, where it is frequently regarded as an invasive species, having previously been native to Europe, North Africa, and Western Asia. The rich anthraquinone, flavonoid and tannin content of <italic>R. frangula</italic> is primarily responsible for its antimicrobial activity (<xref rid="b14-WASJ-7-3-00324" ref-type="bibr">14</xref>). Emodin and frangulin are two examples of anthraquinones that are well-known for having antimicrobial qualities. These substances have the ability to damage microbial cell walls, prevent the synthesis of proteins and obstruct the metabolism of nucleic acids, all of which can result in cell death. Furthermore, as flavonoids can disrupt cell membranes, chelate metal ions and inhibit bacterial enzymes, they broaden the antimicrobial activity spectrum of the plant (<xref rid="b15-WASJ-7-3-00324" ref-type="bibr">15</xref>).</p>
<p>Biofilm formation not only supports bacterial survival, but also amplifies pathogenicity by enhancing resistance to antimicrobial treatments (<xref rid="b16-WASJ-7-3-00324" ref-type="bibr">16</xref>). In vital organs such as the lungs, heart, liver and kidneys, biofilms are often linked to chronic infections and play a crucial role in disease progression. For instance, in the lungs, biofilms formed by pathogens, such as <italic>A. baumannii</italic> play a critical role in conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), driving persistent inflammation and causing tissue damage. Similarly, biofilm-associated bacteria in the liver and kidneys can induce chronic infections, resulting in marked organ dysfunction and disease progression (<xref rid="b17-WASJ-7-3-00324" ref-type="bibr">17</xref>). The role of biofilms in organ damage is largely due to the ability of the bacteria to evade the immune response and persist over long periods of time. This chronic inflammation and infection compromise the integrity of the tissues, leading to scarring, necrosis and functional impairment of the organs. The interplay between biofilm formation and the immune system is crucial in understanding the pathogenesis of these infections and developing more effective treatment strategies to prevent organ damage (<xref rid="b18-WASJ-7-3-00324" ref-type="bibr">18</xref>).</p>
<p>The present study aimed to evaluate the antimicrobial and antibiofilm properties of <italic>R. frangula</italic> against <italic>A. baumannii</italic>. Additionally, it sought to identify, characterize, and analyze the subcellular pathological changes in goat organs—an aspect that, to the best of our knowledge, has not been previously explored. As a pioneering investigation, this research examines both the antibiofilm effects of <italic>R. frangula</italic> on <italic>A. baumannii</italic> and the pathological impact of <italic>A. baumannii</italic> infusion in goat organs, utilizing an innovative approach to assess its potential as a therapeutic agent.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Study design and sample collection</title>
<p>The research study was conducted between March and September, 2024, following approval from the Scientific Review Board of Saveetha Dental College and Hospitals, Chennai, Tamil Nadu, India (SRB/SDC/UG-2276/24/GPATH/076). The approval was granted for the use of goat samples in the present study. <italic>R. frangula</italic> herbal powder was sourced from a botanical garden in Chennai, Tamil Nadu, India. To validate the authenticity, purity and quality of the herbal sample, a certified botanist performed a comprehensive examination and verified its identity. The Authentication and Identification Certificate (SVMC/BOT/272/2023-24) issued by Sri Vidya Mandir Arts &amp; Science College (Autonomous), Katteri, Krishnagiri District, Tamil Nadu, India. This certification confirms that the sample was authenticated based on its morphological characteristics. Following authentication, the powder was stored under controlled conditions for subsequent analysis and utilization in the study.</p>
</sec>
<sec>
<title>Sample extraction</title>
<p>To prepare the extract, 10 g powdered herbal <italic>R. frangula</italic> were combined with 100 ml methanol (Rankem Laboratories, LLC). Throughout the 48-h extraction period, a shaker was used to periodically shake the mixture. Upon completing the extraction process, the suspension was filtered, the temperature of the water bath was regulated to 50˚C, and the methanol solvent was removed from the filtrate. The material was weighed and stored at 4˚C for later use after drying.</p>
</sec>
<sec>
<title>Bacterial culture and conditions</title>
<p>The Malabar Cancer Center in Kerala, India, provided the <italic>A. baumannii</italic> culture samples used in the present study. Luria Bertani (LB) broth (HiMedia Laboratories, LLC) was used to subculture the samples. Subsequently, for 24 h, <italic>A. baumannii</italic> cultures were incubated at 37˚C in a shaking incubator with a speed setting of 100 revolutions per minute (rpm). Both LB agar and Nutrient agar exhiibted distinctive growth patterns. The laboratory staff at Saveetha Dental College and Hospital in Chennai, Tamil Nadu, India, used the VITEK 2 automated system for preliminary identification to confirm the identity of <italic>A. baumannii</italic>, following the methodology described by Bobenchik <italic>et al</italic> (<xref rid="b19-WASJ-7-3-00324" ref-type="bibr">19</xref>).</p>
</sec>
<sec>
<title>Antimicrobial efficacy of R. frangula</title>
<p>The antibacterial activity of <italic>R. frangula</italic> extract was evaluated using the agar well-diffusion method, according to previously established protocols (<xref rid="b20-WASJ-7-3-00324" ref-type="bibr">20</xref>). A bacterial culture of <italic>A. baumannii</italic> was uniformly spread onto Mueller Hinton Agar (MHA) plates (HiMedia, Mumbai, India) using a sterile swab moistened with the bacterial suspension. A well with an 8-mm diameter was carefully punched into the MHA medium using a sterile cork borer. Subsequently, 40 µl <italic>R. frangula</italic> extract (prepared in DMSO at a concentration of 20 mg/ml) were added to the well. DMSO alone was used as a negative control. The plates were incubated at 37˚C for 24 h. Following the incubation period, the zones of inhibition around the wells were measured in millimeters using a vernier caliper to evaluate the antibacterial activity of the extract.</p>
</sec>
<sec>
<title>Drug susceptibility testing</title>
<p>The Kirby-Bauer disk diffusion method was employed to evaluate the antimicrobial susceptibility of <italic>A</italic>. <italic>baumannii</italic>, as previously described (<xref rid="b21-WASJ-7-3-00324" ref-type="bibr">21</xref>). A standardized suspension of <italic>A. baumannii</italic> was evenly spread onto MHA plates using a sterile swab. Disks impregnated with a range of antibiotics commonly used against <italic>A. baumannii</italic>, including tetracycline, piperacillin/tazobactam (PIT), cefixime, imipenem, ceftriaxone, cefotaxime and meropenem (all from HiMedia Laboratories, LLC), were placed on the agar surface. The plates were then incubated at 37˚C for 24 h. Following incubation, the zones of inhibition around the disks were measured in mm to determine bacterial susceptibility.</p>
</sec>
<sec>
<title>Minimum inhibitory concentration assay (MIC)</title>
<p><italic>A. baumannii</italic> is a key nosocomial pathogen known for its ability to develop MDR, rendering treatment options limited (<xref rid="b22-WASJ-7-3-00324" ref-type="bibr">22</xref>). The present study investigated the antimicrobial activity of <italic>R. frangula</italic> extract against <italic>A. baumannii</italic> using the broth dilution method (<xref rid="b20-WASJ-7-3-00324" ref-type="bibr">20</xref>,<xref rid="b23-WASJ-7-3-00324" ref-type="bibr">23</xref>). The MIC of the <italic>R. frangula</italic> extract was determined using a 2-fold broth dilution method, with concentrations ranging from 10 to 0.019 mg/ml. Briefly, a standardized <italic>A. baumannii</italic> inoculum (1.5x10<sup>8</sup> CFU/ml) was added to LB broth containing the various extract concentrations, and the samples were incubated at 37˚C for 24 h. To monitor color changes and validate the findings, 2,3,5-triphenyl tetrazolium chloride (TTC) was transferred to each tube following incubation. A level of concentration at which no color change occurred was considered to be the MIC. Further analysis was conducted at the MIC endpoint for histopathological examination.</p>
</sec>
<sec>
<title>Collection of organ samples</title>
<p>The goat heart, lung, liver, kidney and spleen were carefully sourced from a slaughterhouse in Saidapet, Chennai, Tamil Nadu, India, under the guidance of Professor M. Raman, a veterinary expert from Saveetha Dental College and Hospitals, Chennai, Tamil Nadu, India. Upon procurement, the organs were promptly covered with sterile polyethylene to ensure hygiene and prevent any potential contamination. These samples were then stored at a temperature of 4˚C to preserve their integrity and prevent bacterial growth. The samples were carefully transported to the laboratory, ensuring that the organs remained undamaged during transit. Upon arrival at the laboratory, the organs were placed under refrigeration conditions at -15±4˚C to maintain their quality and suitability for further analysis. This careful handling and storage process ensured that the samples were in optimal condition for subsequent experimental procedures and analysis.</p>
</sec>
<sec>
<title>Infusion of R. frangula extract and bacteria into goat organs</title>
<p>At the end point of MIC of 5 mg/ml, <italic>R. frangula</italic> extract was introduced into a sterile container with brain heart infusion (BHI) (HiMedia Laboratories, LLC) medium. A 20-µl aliquot of <italic>A. baumannii</italic> was added to freshly prepared BHI broth, followed by incubation at 37˚C for 18 h. Following this, a wedge-shaped incision (3 mm) was made in the grossed piece of the goat heart, lung, liver, kidney and spleen, which was subsequently immersed in BHI broth. The previously incubated 20 µl of the bacterial culture was inoculated into the broth. The container was incubated at 37˚C for 24 h, alongside a control group consisting of untreated organs. After 24 h, the organs were processed to assess histopathological changes.</p>
</sec>
<sec>
<title>Histopathology of bacterial infused organs</title>
<p>Hematoxylin and eosin (H&amp;E) staining is a widely utilized method in histopathology to visualize cellular components of tissues. Herein, to preserve tissue structure and to prevent degradation, tissue samples were fixed in 10% formalin (HiMedia Laboratories, LLC) for at least 24 h. The fixed tissues were then dehydrated through a series of increasing ethanol concentrations (70, 80 and 100%) to remove water. Subsequently, the tissues were treated with xylene to eliminate alcohol and prepare them for paraffin infiltration. The tissues were then immersed in molten paraffin wax, embedded in paraffin blocks and allowed to solidify.</p>
<p>Thin tissue sections were obtained using a microtome, cutting them to a thickness of 4-5 µm. These sections were then floated on a water bath to flatten them before being placed on glass slides. To remove the paraffin wax, the slides were immersed in xylene, followed by rehydration through decreasing concentrations of ethanol (100, 80 and 70%) and a rinse in distilled water. The slides were then stained with hematoxylin (Sigma-Aldrich, USA) at room temperature (25±2˚C) for 5-10 min, rinsed in tap water, and differentiated in acid alcohol (1% HCl in 70% ethanol). Following another rinse in tap water, the slides were ‘blued’ by immersion in a weak alkaline solution (e.g., 0.1% ammonia water) or tap water until the nuclei appear blue. The slides were then stained with eosin (MilliporeSigma) at room temperature (25±2˚C) for 1-3 min and briefly rinsed in tap water. Dehydration is performed again by passing the slides through increasing concentrations of ethanol (70, 80 and 100%) to remove water, followed by immersion in xylene to eliminate ethanol and prepare for mounting. A drop of mounting medium was applied to the slide, and a coverslip was placed over the tissue sections. After allowing the sections to dry, the stained sections were examined under a light microscope (CX23, Olympus Corporation) to observe the cellular and tissue structures (<xref rid="b24-WASJ-7-3-00324" ref-type="bibr">24</xref>).</p>
<p>Further experimental analysis was conducted to evaluate the antibiofilm activity and growth curve of <italic>R. frangula</italic> extract at sub-MIC concentrations against <italic>A. baumannii.</italic></p>
</sec>
<sec>
<title>Biofilm assay</title>
<p>To evaluate the effects of <italic>R. frangula</italic> extract on <italic>A. baumannii</italic> biofilm formation, a crystal violet staining assay was employed as previously described by Venkatraman <italic>et al</italic> (<xref rid="b25-WASJ-7-3-00324" ref-type="bibr">25</xref>). A microtiter plate containing 180 µl fresh LB medium was first filled with an overnight culture of <italic>A. baumannii</italic> (20 µl). Subsequenlty, <italic>R. frangula</italic> extract was added at concentrations ranging from 2.5 to 0.004 mg/ml, which is after the MIC point. For 48 h, the mixture was incubated at 37˚C. Following incubation, the biofilm that stuck to the surface was stained for 2 min at room temperature using a 0.1% crystal violet solution (HiMedia Laboratories, LLC), and the planktonic cells were eliminated by rinsing with sterile distilled water at room temperature. The crystal violet-bound biofilm was then eluted with 200 µl 70% ethanol after a 10-min incubation. The absorbance of the eluted crystal violet was measured at 520 nm using a UV-Vis spectrophotometer (JASCO UV/Vis, India). Biofilm inhibition (%) was calculated using the following formula:: (Control OD 520 nm - treated OD 520 nm)/control OD 520 nm x100.</p>
</sec>
<sec>
<title>A. baumannii growth analysis</title>
<p><italic>A. baumannii</italic> bacterial development was examined using <italic>R. frangula</italic> extract at 1.25 mg/ml doses or the extract. The culture was incubated at 37˚C for up to 24 h, and the cell density was measured at OD 600 nm every hour.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments were performed in triplicate, and the biofilm assay (crystal violet assay), and growth curve demonstrated statistical significance. The data were analyzed using one-way ANOVA followed by Tukey's Honest Significant Difference (HSD) test, performed with GraphPad Prism 10.1.0 software (Dotmatics). A P-value &lt;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Antimicrobial activity of R. frangula</title>
<p>The antimicrobial potential of <italic>R. frangula</italic> extract was evaluated using the agar well diffusion method against <italic>A. baumannii</italic>. The results revealed a distinct zone of inhibition measuring 16 mm (<xref rid="f1-WASJ-7-3-00324" ref-type="fig">Fig. 1</xref>), indicating a significant level of antimicrobial efficacy against this pathogen. This suggests that <italic>R. frangula</italic> extract possesses the capability to inhibit the growth of <italic>A. baumannii</italic>, which is particularly relevant given the MDR nature of the pathogen.</p>
</sec>
<sec>
<title>Antibiotic sensitivity patterns</title>
<p>The antibiotic resistance patterns of <italic>A. baumannii</italic> were assessed using a panel of different antibiotic discs. The findings indicated that the majority of the antibiotics tested were ineffective against <italic>A. baumannii</italic>, highlighting a notable level of MDR (<xref rid="tI-WASJ-7-3-00324" ref-type="table">Table I</xref>). This extensive resistance complicates treatment options and underscores the urgent need for new therapeutic strategies.</p>
</sec>
<sec>
<title>Bactericidal activity at the MIC level</title>
<p>The inhibitory effect of <italic>R. frangula</italic> extract was assessed using a 2-fold serial dilution method, with concentrations ranging from 10 to 0.019 mg/ml. The results revealed that the growth of <italic>A. baumannii</italic> was effectively inhibited at a concentration of 5 mg/ml (<xref rid="tII-WASJ-7-3-00324" ref-type="table">Table II</xref>). Subsequently, the potential antibiofilm properties of <italic>R. frangula</italic> at sub-MIC concentrations were further investigated. This additional analyses aimed to explore whether lower, non-lethal concentrations of the extract could disrupt or prevent biofilm formation, which is a key factor in the persistence and resistance of <italic>A. baumannii</italic> in clinical settings.</p>
</sec>
<sec>
<title>Findings of the histopathological analysis</title>
<p>As evidenced herein, the infiltration of the bacterium <italic>A. baumannii</italic> leads to the marked disintegration of myofibrils. This bacterial presence triggers the degeneration of myofibers, which is accompanied by a dense inflammatory infiltrate. The extensive inflammatory response exacerbates the damage to muscle tissue, resulting in the breakdown of myofibril structure and contributing to overall muscle degeneration. This complex pathological process underscores the aggressive nature of <italic>A. baumannii</italic> infection and its detrimental effects on muscle integrity (<xref rid="f2-WASJ-7-3-00324" ref-type="fig">Fig. 2</xref>). As illustrated in <xref rid="f2-WASJ-7-3-00324" ref-type="fig">Fig. 2D</xref>, the cardiac tissue treated with 5 mg/ml <italic>R. frangula</italic> extract exhibited a gradual reduction in bacterial load and a corresponding decrease in inflammatory cell infiltration.</p>
<p>An H&amp;E-stained section of the lung tissue revealed diffuse alveolar damage accompanied by marked inflammatory infiltrate. Following the infusion of the bacterium <italic>A. baumannii</italic>, there was a marked increase in alveolar septal thickening. This pathological alteration indicated severe lung tissue injury, characterized by widespread damage to the alveolar structures and intensified inflammatory response, leading to the thickening of the alveolar walls. The histopathological findings highlight the extensive impact of <italic>A. baumannii</italic> infection on lung tissue architecture and function (<xref rid="f3-WASJ-7-3-00324" ref-type="fig">Fig. 3</xref>). As illustrated in <xref rid="f3-WASJ-7-3-00324" ref-type="fig">Fig. 3D</xref>, the lung tissue treated with the endpoint MIC of <italic>R. frangula</italic> extract at 5 mg/ml exhibited a reduction in bacterial load, along with a noticeable decrease in inflammatory cell infiltration.</p>
<p>The hepatocytes demonstrated vacuolar degeneration accompanied by the infiltration of <italic>A. baumannii</italic> (<xref rid="f4-WASJ-7-3-00324" ref-type="fig">Fig. 4A</xref>). Following treatment with 5 mg/ml <italic>R. frangula</italic> extract, there was a marked decrease in the bacterial load (<xref rid="f4-WASJ-7-3-00324" ref-type="fig">Fig. 4B</xref>). The spleen exhibited widespread degeneration of the germinal centers, accompanied by infiltration of <italic>A. baumannii</italic> (<xref rid="f5-WASJ-7-3-00324" ref-type="fig">Fig. 5A</xref>). This was associated with a significant bacterial load and a dense inflammatory infiltrate. However, following treatment with 5 mg/ml <italic>R. frangula</italic> extract, there was a notable reduction in the bacterial load (<xref rid="f5-WASJ-7-3-00324" ref-type="fig">Fig. 5B</xref>).</p>
<p>The spleen revealed generalized degeneration in the kidney tubules, with certain regions of Bowman's capsule showing infiltration by <italic>A. baumannii</italic> and a chronic inflammatory response (<xref rid="f6-WASJ-7-3-00324" ref-type="fig">Fig. 6A</xref>). Additionally, areas of the kidney and Bowman's capsule exhibited vacuolar degeneration. Following treatment with 5 mg/ml <italic>R. frangula</italic> extract, there was a notable decrease in bacterial load, indicating a therapeutic effect on the infected tissues (<xref rid="f6-WASJ-7-3-00324" ref-type="fig">Fig. 6B</xref>).</p>
</sec>
<sec>
<title>Inhibition of biofilm formation in A. baumannii</title>
<p>The inhibitory effect of <italic>R. frangula</italic> extract on the ability of <italic>A. baumannii</italic> to form biofilms was investigated using the static microtiter plate method, with 0.1% crystal violet staining to quantify biofilm biomass. The results revealed that <italic>R. frangula</italic> extract significantly inhibited biofilm formation (P&lt;0.05, significant difference compared to the untreated control) with spectrophotometric analysis revealing 67.26% inhibition at 2.5 mg/ml and 58.22% inhibition at 1.25 mg/ml (<xref rid="f7-WASJ-7-3-00324" ref-type="fig">Fig. 7</xref>).</p>
</sec>
<sec>
<title>Analysis the growth of A. baumannii</title>
<p>The growth curve analysis was applied both with and without the <italic>R. frangula</italic> extract. <xref rid="f8-WASJ-7-3-00324" ref-type="fig">Fig. 8</xref> demonstrates that at a dose of 2.5 mg/ml, <italic>R. frangula</italic> extract did not inhibit the growth of <italic>A. baumannii</italic>. Spectrophotometric measurements showed no appreciable difference between the treated and control bacterial cells at 600 nm. These findings suggest that <italic>R. frangula</italic> extract does not inhibit the planktonic growth of <italic>A. baumannii</italic> at 2.5 mg/ml also effectively reduces its ability to form biofilms.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p><italic>A. baumannii</italic> is considered one of the most hazardous bacteria associated with healthcare-related infections. Its marked ability to acquire antibiotic resistance and persist in diverse environments poses a significant challenge in clinical settings. In the present study, a series of <italic>in vitro</italic> experiments demonstrated that <italic>R. frangula</italic> extract effectively reduced <italic>A. baumannii</italic> biofilm formation, highlighting its potential as a therapeutic agent. Similarly, Zhou <italic>et al</italic> (<xref rid="b26-WASJ-7-3-00324" ref-type="bibr">26</xref>) demonstrated that <italic>P. aeruginosa</italic> three quorum sensing (QS) systems were inhibited by hordenine, an herbal extract made from sprouting barley.</p>
<p>In the present study, at a MIC of 5 mg/ml, the initial results demonstrated that the bactericidal activity of <italic>A. baumannii</italic> was inhibited by <italic>R. frangula</italic> extract. This observation is consistent with the findings of a previous study demonstrating that methanolic extracts of <italic>Cuminum cyminum</italic> can inhibit Gram-negative bacteria at MIC levels (<xref rid="b27-WASJ-7-3-00324" ref-type="bibr">27</xref>). Additionally, it has been noted that aloe vera gel extract is more effective against Gram-positive than Gram-negative bacteria, with ethanol and methanol extracts exhibiting the highest activity, while acetone extract exhibited the least inhibition (<xref rid="b28-WASJ-7-3-00324" ref-type="bibr">28</xref>). Furthermore, in the present study, <italic>R. frangula</italic> extract inhibited QS-regulated biofilm formation in <italic>A. baumannii</italic> in a concentration-dependent manner at sub-MIC concentrations. Specifically, the crystal violet assay revealed that a concentration of 2.5 mg/ml <italic>R. frangula</italic> extract markedly decreased biofilm formation without influencing planktonic cell growth (<xref rid="f7-WASJ-7-3-00324" ref-type="fig">Figs. 7</xref> and <xref rid="f8-WASJ-7-3-00324" ref-type="fig">8</xref>). Miyasaki <italic>et al</italic> (<xref rid="b29-WASJ-7-3-00324" ref-type="bibr">29</xref>) also reported that specific compounds in herbal extracts, such as flavones, tannins, and phenolic compounds, are generally known for their anti-<italic>Acinetobacter</italic> activity.</p>
<p>The discussion on biofilm formation and its pathological implications in vital organs highlights the crucial role of biofilms in chronic infections. Biofilm formation is a key survival mechanism for bacteria, enhancing their resistance to antimicrobial treatments and the immune system (<xref rid="b30-WASJ-7-3-00324" ref-type="bibr">30</xref>). The ability of bacteria to form biofilms, particularly in organs such as the lungs, liver and kidneys, contributes to persistent infections that are challenging to eradicate, often leading to prolonged inflammation and organ damage (<xref rid="b31-WASJ-7-3-00324" ref-type="bibr">31</xref>). Infections caused by <italic>A. baumannii</italic>, a notorious biofilm producer, exemplify this phenomenon, particularly in the lungs where biofilms are involved in severe respiratory diseases such as cystic fibrosis and COPD (<xref rid="b32-WASJ-7-3-00324" ref-type="bibr">32</xref>).</p>
<p>In the present study, <italic>A. baumannii</italic> infiltrations induced notable pathological changes, including disintegration of myofibrils in cardiac muscle and extensive damage to alveolar structures in the lungs, which were effectively mitigated with 5 mg/ml <italic>R. frangula</italic> extract. These findings are consistent with those of previous research, demonstrating that biofilm-producing bacteria exacerbate tissue damage by triggering chronic inflammatory responses, which further deteriorate tissue architecture (<xref rid="b33-WASJ-7-3-00324" ref-type="bibr">33</xref>). The persistent presence of bacterial biofilms hinders the effectiveness of immune clearance, allowing the bacteria to persist and cause scarring, necrosis and the functional impairment of vital organs over time (<xref rid="b34-WASJ-7-3-00324" ref-type="bibr">34</xref>).</p>
<p>An innovative feature of the present study lies in its use of <italic>ex vivo</italic> goat models to evaluate the effects of <italic>R. frangula</italic> extract on <italic>A. baumannii</italic> biofilms, an approach that has not been extensively explored in previous research to date, at least to the best of our knowledge. This biologically relevant platform bridges the gap between <italic>in vitro</italic> findings and potential <italic>in vivo</italic> applications, providing a more comprehensive assessment of the extract's efficacy. Furthermore, the holistic evaluation of antimicrobial and antibiofilm activity, along with its impact on histopathological changes across multiple organ systems (heart, lungs, liver, kidney and spleen), underscores the therapeutic potential of the extract and its ability to preserve tissue integrity.</p>
<p>The present study opens several promising avenues for future research. The <italic>ex vivo</italic> goat organ model provides valuable insight into the potential of <italic>R. frangula</italic> extract for the management of <italic>A. baumannii</italic>-associated infections. Expanding this research to include human clinical settings will enable a more comprehensive evaluation of the extract's efficacy and safety. Rigorous clinical trials could further establish its therapeutic potential and bridge the gap to clinical applications. Additionally, the present study investigated only a single isolate of <italic>A. baumannii</italic>, which may limit the broader applicability of the findings. Future studies are thus required to involve a diverse range of clinical isolates to ensure the consistency and generalizability of the results. Moreover, the findings of the present study on biofilm inhibition create opportunities to delve deeper into the molecular mechanisms behind this activity. A more detailed exploration could illuminate the mode of action of the extract, paving the way for innovative strategies, such as combining <italic>R. frangula</italic> with conventional antibiotics to enhance therapeutic outcomes.</p>
<p>Taken together, the findings of the present study provide compelling evidence of the therapeutic potential of <italic>R. frangula</italic> extract against <italic>A. baumannii</italic> biofilms, while also recognizing its inherent strengths and limitations. These findings contribute to the ongoing efforts to combat antibiotic-resistant infections and underscore the importance of further studies to fully explore and realize the clinical applicability of this natural remedy.</p>
<p>In conclusion, the results of the present study demonstrate the potential of <italic>R. frangula</italic> extract as a beneficial treatment choice for <italic>A. baumannii</italic> infections. The present study demonstrates the complex role of biofilms in promoting bacterial persistence and tissue damage, while also shedding light on the potential of natural compounds to mitigate these effects. Further investigations are required however, to on the molecular mechanisms underlying the biofilm-inhibitory properties of <italic>R. frangula</italic>, contributing to the development of novel therapeutic strategies for biofilm-associated infections.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study may be requested from the corresponding author.</p>
</sec>
<sec>
<title>Authors' contributions</title>
<p>RMRV collected, managed the data and participated in the writing of the manuscript. PR and NNP participated in writing the proposal, performing data collection and in the writing of the manuscript. PR and PSG were involved in data curation, data analysis and in revising the manuscript. PR, NNP and PSG confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The present study was approved by the Scientific Review Board of Saveetha Dental College and Hospitals, Chennai, Tamil Nadu, India (SRB/SDC/UG-2276/24/GPATH/076). The approval was granted for the use of goat samples.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-WASJ-7-3-00324"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>S</given-names></name><name><surname>Al-Saryi</surname><given-names>N</given-names></name><name><surname>Al-Kadmy</surname><given-names>IMS</given-names></name><name><surname>Aziz</surname><given-names>SN</given-names></name></person-group><article-title>Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals</article-title><source>Mol Biol Rep</source><volume>48</volume><fpage>6987</fpage><lpage>6998</lpage><year>2021</year><pub-id pub-id-type="pmid">34460060</pub-id><pub-id pub-id-type="doi">10.1007/s11033-021-06690-6</pub-id></element-citation></ref>
<ref id="b2-WASJ-7-3-00324"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathoor</surname><given-names>NN</given-names></name><name><surname>Ganesh</surname><given-names>PS</given-names></name><name><surname>Gopal</surname><given-names>RK</given-names></name></person-group><article-title>Microbiome interactions: Acinetobacter baumannii biofilms as a co-factor in oral cancer progression</article-title><source>World J Microbiol Biotechnol</source><volume>40</volume><issue>398</issue><year>2024</year><pub-id pub-id-type="pmid">39612015</pub-id><pub-id pub-id-type="doi">10.1007/s11274-024-04208-3</pub-id></element-citation></ref>
<ref id="b3-WASJ-7-3-00324"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedefie</surname><given-names>A</given-names></name><name><surname>Demsis</surname><given-names>W</given-names></name><name><surname>Ashagrie</surname><given-names>M</given-names></name><name><surname>Kassa</surname><given-names>Y</given-names></name><name><surname>Tesfaye</surname><given-names>M</given-names></name><name><surname>Tilahun</surname><given-names>M</given-names></name><name><surname>Bisetegn</surname><given-names>H</given-names></name><name><surname>Sahle</surname><given-names>Z</given-names></name></person-group><article-title>Biofilm formation and its role in disease pathogenesis: A review</article-title><source>Infect Drug Resist</source><volume>14</volume><fpage>3711</fpage><lpage>3719</lpage><year>2021</year><pub-id pub-id-type="pmid">34531666</pub-id><pub-id pub-id-type="doi">10.2147/IDR.S332051</pub-id></element-citation></ref>
<ref id="b4-WASJ-7-3-00324"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>C</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><name><surname>Wille</surname><given-names>J</given-names></name><name><surname>Xanthopoulou</surname><given-names>K</given-names></name><name><surname>Stefanik</surname><given-names>D</given-names></name><name><surname>Grundmann</surname><given-names>H</given-names></name><name><surname>Higgins</surname><given-names>PG</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name></person-group><article-title>A global view on carbapenem-resistant Acinetobacter baumannii</article-title><source>mBio</source><volume>14</volume><issue>e0226023</issue><year>2023</year><pub-id pub-id-type="pmid">37882512</pub-id><pub-id pub-id-type="doi">10.1128/mbio.02260-23</pub-id></element-citation></ref>
<ref id="b5-WASJ-7-3-00324"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girija</surname><given-names>ASS</given-names></name></person-group><article-title>Acinetobacter baumannii as an oro-dental pathogen: A red alert!!</article-title><source>J Appl Oral Sci</source><volume>32</volume><issue>e20230382</issue><year>2024</year><pub-id pub-id-type="pmid">38747806</pub-id><pub-id pub-id-type="doi">10.1590/1678-7757-2023-0382</pub-id></element-citation></ref>
<ref id="b6-WASJ-7-3-00324"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loehfelm</surname><given-names>TW</given-names></name><name><surname>Luke</surname><given-names>NR</given-names></name><name><surname>Campagnari</surname><given-names>AA</given-names></name></person-group><article-title>Identification and characterization of an Acinetobacter baumannii biofilm-associated protein</article-title><source>J Bacteriol</source><volume>190</volume><fpage>1036</fpage><lpage>1044</lpage><year>2008</year><pub-id pub-id-type="pmid">18024522</pub-id><pub-id pub-id-type="doi">10.1128/JB.01416-07</pub-id></element-citation></ref>
<ref id="b7-WASJ-7-3-00324"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>L</given-names></name><name><surname>Patil</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name></person-group><article-title>A growing battlefield in the war against biofilm-induced antimicrobial resistance: Insights from reviews on antibiotic resistance</article-title><source>Front Cell Infect Microbiol</source><volume>13</volume><issue>1327069</issue><year>2023</year><pub-id pub-id-type="pmid">38188636</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1327069</pub-id></element-citation></ref>
<ref id="b8-WASJ-7-3-00324"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smiline Girija</surname><given-names>SA</given-names></name></person-group><article-title>Hijacking the epigenetic mechanisms of A. baumannii</article-title><source>Mol Biol Res Commun</source><volume>13</volume><fpage>51</fpage><lpage>53</lpage><year>2024</year><pub-id pub-id-type="pmid">38504783</pub-id><pub-id pub-id-type="doi">10.22099/MBRC.2024.48801.1899</pub-id></element-citation></ref>
<ref id="b9-WASJ-7-3-00324"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathoor</surname><given-names>NN</given-names></name><name><surname>Viswanathan</surname><given-names>A</given-names></name><name><surname>Wadhwa</surname><given-names>G</given-names></name><name><surname>Ganesh</surname><given-names>PS</given-names></name></person-group><article-title>Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection</article-title><source>APMIS</source><volume>132</volume><fpage>317</fpage><lpage>335</lpage><year>2024</year><pub-id pub-id-type="pmid">38444124</pub-id><pub-id pub-id-type="doi">10.1111/apm.13399</pub-id></element-citation></ref>
<ref id="b10-WASJ-7-3-00324"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohajeri</surname><given-names>P</given-names></name><name><surname>Farahani</surname><given-names>A</given-names></name><name><surname>Feizabadi</surname><given-names>MM</given-names></name><name><surname>Norozi</surname><given-names>B</given-names></name></person-group><article-title>Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis</article-title><source>Indian J Med Microbiol</source><volume>33</volume><fpage>87</fpage><lpage>91</lpage><year>2015</year><pub-id pub-id-type="pmid">25560008</pub-id><pub-id pub-id-type="doi">10.4103/0255-0857.148390</pub-id></element-citation></ref>
<ref id="b11-WASJ-7-3-00324"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohajeri</surname><given-names>P</given-names></name><name><surname>Sharbati</surname><given-names>S</given-names></name><name><surname>Farahani</surname><given-names>A</given-names></name><name><surname>Rezaei</surname><given-names>Z</given-names></name></person-group><article-title>Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah</article-title><source>J Nat Sci Biol Med</source><volume>7</volume><fpage>58</fpage><lpage>61</lpage><year>2016</year><pub-id pub-id-type="pmid">27003971</pub-id><pub-id pub-id-type="doi">10.4103/0976-9668.175071</pub-id></element-citation></ref>
<ref id="b12-WASJ-7-3-00324"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasim</surname><given-names>N</given-names></name><name><surname>Sandeep</surname><given-names>IS</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name></person-group><article-title>Plant-derived natural products for drug discovery: Current approaches and prospects</article-title><source>Nucleus (Calcutta)</source><volume>65</volume><fpage>399</fpage><lpage>411</lpage><year>2022</year><pub-id pub-id-type="pmid">36276225</pub-id><pub-id pub-id-type="doi">10.1007/s13237-022-00405-3</pub-id></element-citation></ref>
<ref id="b13-WASJ-7-3-00324"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalinowska</surname><given-names>M</given-names></name><name><surname>Gołębiewska</surname><given-names>E</given-names></name><name><surname>Świderski</surname><given-names>G</given-names></name><name><surname>Męczyńska-Wielgosz</surname><given-names>S</given-names></name><name><surname>Lewandowska</surname><given-names>H</given-names></name><name><surname>Pietryczuk</surname><given-names>A</given-names></name><name><surname>Cudowski</surname><given-names>A</given-names></name><name><surname>Astel</surname><given-names>A</given-names></name><name><surname>Świsłocka</surname><given-names>R</given-names></name><name><surname>Samsonowicz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Plant-derived and dietary hydroxybenzoic acids-a comprehensive study of structural, anti-/pro-oxidant, lipophilic, antimicrobial, and cytotoxic activity in MDA-MB-231 and MCF-7 cell lines</article-title><source>Nutrients</source><volume>13</volume><issue>3107</issue><year>2021</year><pub-id pub-id-type="pmid">34578985</pub-id><pub-id pub-id-type="doi">10.3390/nu13093107</pub-id></element-citation></ref>
<ref id="b14-WASJ-7-3-00324"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenleaf</surname><given-names>J</given-names></name><name><surname>Karimzadeh</surname><given-names>R</given-names></name><name><surname>Park</surname><given-names>YL</given-names></name></person-group><article-title>Spatial patterns of Frangula alnus (Rosales: Rhamnaceae): Implications for invasive plant management</article-title><source>Biology (Basel)</source><volume>12</volume><issue>1393</issue><year>2023</year><pub-id pub-id-type="pmid">37997992</pub-id><pub-id pub-id-type="doi">10.3390/biology12111393</pub-id></element-citation></ref>
<ref id="b15-WASJ-7-3-00324"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Górniak</surname><given-names>I</given-names></name><name><surname>Bartoszewski</surname><given-names>R</given-names></name><name><surname>Króliczewski</surname><given-names>J</given-names></name></person-group><article-title>Comprehensive review of antimicrobial activities of plant flavonoids</article-title><source>Phytochem Rev</source><volume>18</volume><fpage>241</fpage><lpage>272</lpage><year>2019</year></element-citation></ref>
<ref id="b16-WASJ-7-3-00324"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahiri</surname><given-names>D</given-names></name><name><surname>Nag</surname><given-names>M</given-names></name><name><surname>Ray</surname><given-names>RR</given-names></name><name><surname>Ghosh</surname><given-names>S (eds)</given-names></name></person-group><comment>Biofilm-Associated Antimicrobial Resistance and Its Recovery. CRC Press, Boca Raton, p391, 2023.</comment></element-citation></ref>
<ref id="b17-WASJ-7-3-00324"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Chandra</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>L</given-names></name><name><surname>Hashmi</surname><given-names>MZ</given-names></name><name><surname>Varma</surname><given-names>A (eds)</given-names></name></person-group><comment>Biofilms in Human Diseases: Treatment and Control. Springer Nature, p318, 2019.</comment></element-citation></ref>
<ref id="b18-WASJ-7-3-00324"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labis</surname><given-names>V</given-names></name><name><surname>Gaiduk</surname><given-names>I</given-names></name><name><surname>Bazikyan</surname><given-names>E</given-names></name><name><surname>Khmelenin</surname><given-names>D</given-names></name><name><surname>Zhigalina</surname><given-names>O</given-names></name><name><surname>Dyachkova</surname><given-names>I</given-names></name><name><surname>Zolotov</surname><given-names>D</given-names></name><name><surname>Asadchikov</surname><given-names>V</given-names></name><name><surname>Kravtsov</surname><given-names>I</given-names></name><name><surname>Polyakov</surname><given-names>N</given-names></name><etal/></person-group><article-title>The role of metal nanoparticles in the pathogenesis of stone formation</article-title><source>Int J Mol Sci</source><volume>25</volume><issue>9609</issue><year>2024</year><pub-id pub-id-type="pmid">39273555</pub-id><pub-id pub-id-type="doi">10.3390/ijms25179609</pub-id></element-citation></ref>
<ref id="b19-WASJ-7-3-00324"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobenchik</surname><given-names>AM</given-names></name><name><surname>Deak</surname><given-names>E</given-names></name><name><surname>Hindler</surname><given-names>JA</given-names></name><name><surname>Charlton</surname><given-names>CL</given-names></name><name><surname>Humphries</surname><given-names>RM</given-names></name></person-group><article-title>Performance of Vitek 2 for antimicrobial susceptibility testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th edition breakpoints</article-title><source>J Clin Microbiol</source><volume>55</volume><fpage>450</fpage><lpage>456</lpage><year>2017</year><pub-id pub-id-type="pmid">27881616</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01859-16</pub-id></element-citation></ref>
<ref id="b20-WASJ-7-3-00324"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>M</given-names></name><name><surname>Naseef Pathoor</surname><given-names>N</given-names></name><name><surname>Viswanathan</surname><given-names>A</given-names></name><name><surname>Veeraragavan</surname><given-names>GR</given-names></name><name><surname>Sankar Ganesh</surname><given-names>P</given-names></name></person-group><article-title>Exploring the antimicrobial and antibiofilm activities of Artocarpus heterophyllus Lam. against Pseudomonas aeruginosa PAO1</article-title><source>World Acad Sci J</source><volume>6</volume><issue>50</issue><year>2024</year></element-citation></ref>
<ref id="b21-WASJ-7-3-00324"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudzicki</surname><given-names>J</given-names></name></person-group><comment>Kirby-Bauer Disk Diffusion Susceptibility Test Protocol. American Society for Microbiology, Washington, DC, pp55-63, 2009.</comment></element-citation></ref>
<ref id="b22-WASJ-7-3-00324"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>A</given-names></name><name><surname>O'Donoghue</surname><given-names>M</given-names></name><name><surname>Feeney</surname><given-names>A</given-names></name><name><surname>Sleator</surname><given-names>RD</given-names></name></person-group><article-title>Acinetobacter baumannii: An emerging opportunistic pathogen</article-title><source>Virulence</source><volume>3</volume><fpage>243</fpage><lpage>250</lpage><year>2012</year><pub-id pub-id-type="pmid">22546906</pub-id><pub-id pub-id-type="doi">10.4161/viru.19700</pub-id></element-citation></ref>
<ref id="b23-WASJ-7-3-00324"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peer Mohammed</surname><given-names>S</given-names></name><name><surname>Pathoor</surname><given-names>N</given-names></name><name><surname>Veeraragavan</surname><given-names>G</given-names></name><name><surname>Ganesh</surname><given-names>P</given-names></name></person-group><article-title>Unlocking the antibiofilm and anti-virulence potential of Pithecellobium dulce against Chromobacterium violaceum CV12472</article-title><source>World Acad Sci J</source><volume>7</volume><issue>14</issue><year>2024</year></element-citation></ref>
<ref id="b24-WASJ-7-3-00324"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bancroft</surname><given-names>JD</given-names></name><name><surname>Gamble</surname><given-names>M (eds)</given-names></name></person-group><comment>Theory and practice of histological techniques. 6th edition. Elsevier Health Sciences, p744, 2008.</comment></element-citation></ref>
<ref id="b25-WASJ-7-3-00324"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatramanan</surname><given-names>M</given-names></name><name><surname>Sankar Ganesh</surname><given-names>P</given-names></name><name><surname>Senthil</surname><given-names>R</given-names></name><name><surname>Akshay</surname><given-names>J</given-names></name><name><surname>Veera Ravi</surname><given-names>A</given-names></name><name><surname>Langeswaran</surname><given-names>K</given-names></name><name><surname>Vadivelu</surname><given-names>J</given-names></name><name><surname>Nagarajan</surname><given-names>S</given-names></name><name><surname>Rajendran</surname><given-names>K</given-names></name><name><surname>Shankar</surname><given-names>EM</given-names></name></person-group><article-title>Inhibition of quorum sensing and biofilm formation in Chromobacterium violaceum by fruit extracts of Passiflora edulis</article-title><source>ACS Omega</source><volume>5</volume><fpage>25605</fpage><lpage>25616</lpage><year>2020</year><pub-id pub-id-type="pmid">33073086</pub-id><pub-id pub-id-type="doi">10.1021/acsomega.0c02483</pub-id></element-citation></ref>
<ref id="b26-WASJ-7-3-00324"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>JW</given-names></name><name><surname>Luo</surname><given-names>HZ</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Jian</surname><given-names>TK</given-names></name><name><surname>Chen</surname><given-names>ZQ</given-names></name><name><surname>Jia</surname><given-names>AQ</given-names></name></person-group><article-title>Hordenine: A novel quorum sensing inhibitor and antibiofilm agent against Pseudomonas aeruginosa</article-title><source>J Agric Food Chem</source><volume>66</volume><fpage>1620</fpage><lpage>1628</lpage><year>2018</year><pub-id pub-id-type="pmid">29353476</pub-id><pub-id pub-id-type="doi">10.1021/acs.jafc.7b05035</pub-id></element-citation></ref>
<ref id="b27-WASJ-7-3-00324"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sybiya Vasantha Packiavathy</surname><given-names>IA</given-names></name><name><surname>Agilandeswari</surname><given-names>P</given-names></name><name><surname>Musthafa</surname><given-names>KS</given-names></name><name><surname>Karutha Pandian</surname><given-names>S</given-names></name><name><surname>Veera Ravi</surname><given-names>A</given-names></name></person-group><article-title>Antibiofilm and quorum sensing inhibitory potential of Cuminum cyminum and its secondary metabolite methyl eugenol against gram-negative bacterial pathogens</article-title><source>Food Res Int</source><volume>45</volume><fpage>85</fpage><lpage>92</lpage><year>2012</year></element-citation></ref>
<ref id="b28-WASJ-7-3-00324"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>R</given-names></name><name><surname>Tripathi</surname><given-names>P</given-names></name><name><surname>Jeyakumar</surname><given-names>E</given-names></name></person-group><article-title>Isolation, purification and evaluation of antibacterial agents from Aloe vera</article-title><source>Braz J Microbiol</source><volume>40</volume><fpage>906</fpage><lpage>915</lpage><year>2009</year><pub-id pub-id-type="pmid">24031440</pub-id><pub-id pub-id-type="doi">10.1590/S1517-838220090004000023</pub-id></element-citation></ref>
<ref id="b29-WASJ-7-3-00324"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyasaki</surname><given-names>Y</given-names></name><name><surname>Rabenstein</surname><given-names>JD</given-names></name><name><surname>Rhea</surname><given-names>J</given-names></name><name><surname>Crouch</surname><given-names>ML</given-names></name><name><surname>Mocek</surname><given-names>UM</given-names></name><name><surname>Kittell</surname><given-names>PE</given-names></name><name><surname>Morgan</surname><given-names>MA</given-names></name><name><surname>Nichols</surname><given-names>WS</given-names></name><name><surname>Van Benschoten</surname><given-names>MM</given-names></name><name><surname>Hardy</surname><given-names>WD</given-names></name><name><surname>Liu</surname><given-names>GY</given-names></name></person-group><article-title>Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii</article-title><source>PLoS One</source><volume>8</volume><issue>e61594</issue><year>2013</year><pub-id pub-id-type="pmid">23630600</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061594</pub-id></element-citation></ref>
<ref id="b30-WASJ-7-3-00324"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Shuai</surname><given-names>W</given-names></name><name><surname>Sumner</surname><given-names>JT</given-names></name><name><surname>Moghadam</surname><given-names>AA</given-names></name><name><surname>Hartmann</surname><given-names>EM</given-names></name></person-group><article-title>Clinically relevant pathogens on surfaces display differences in survival and transcriptomic response in relation to probiotic and traditional cleaning strategies</article-title><source>NPJ Biofilms Microbiomes</source><volume>8</volume><issue>72</issue><year>2022</year><pub-id pub-id-type="pmid">36123373</pub-id><pub-id pub-id-type="doi">10.1038/s41522-022-00335-7</pub-id></element-citation></ref>
<ref id="b31-WASJ-7-3-00324"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XZ</given-names></name><name><surname>Elkins</surname><given-names>CA</given-names></name><name><surname>Zgurskaya</surname><given-names>HI</given-names></name></person-group><comment>Efflux-mediated antimicrobial resistance in bacteria: mechanisms, regulation and clinical implications. Springer, New York, NY, p848, 2016.</comment></element-citation></ref>
<ref id="b32-WASJ-7-3-00324"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grygiel</surname><given-names>I</given-names></name><name><surname>Bajrak</surname><given-names>O</given-names></name><name><surname>Wójcicki</surname><given-names>M</given-names></name><name><surname>Krusiec</surname><given-names>K</given-names></name><name><surname>Jończyk-Matysiak</surname><given-names>E</given-names></name><name><surname>Górski</surname><given-names>A</given-names></name><name><surname>Majewska</surname><given-names>J</given-names></name><name><surname>Letkiewicz</surname><given-names>S</given-names></name></person-group><article-title>Comprehensive approaches to combatting Acinetobacter baumannii biofilms: From biofilm structure to phage-based therapies</article-title><source>Antibiotics (Basel)</source><volume>13</volume><issue>1064</issue><year>2024</year><pub-id pub-id-type="pmid">39596757</pub-id><pub-id pub-id-type="doi">10.3390/antibiotics13111064</pub-id></element-citation></ref>
<ref id="b33-WASJ-7-3-00324"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendhe</surname><given-names>S</given-names></name><name><surname>Badge</surname><given-names>A</given-names></name><name><surname>Ugemuge</surname><given-names>S</given-names></name><name><surname>Chandi</surname><given-names>D</given-names></name></person-group><article-title>Impact of biofilms on chronic infections and medical challenges</article-title><source>Cureus</source><volume>15</volume><issue>e48204</issue><year>2023</year><pub-id pub-id-type="pmid">38050493</pub-id><pub-id pub-id-type="doi">10.7759/cureus.48204</pub-id></element-citation></ref>
<ref id="b34-WASJ-7-3-00324"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostakioti</surname><given-names>M</given-names></name><name><surname>Hadjifrangiskou</surname><given-names>M</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><article-title>Bacterial biofilms: Development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era</article-title><source>Cold Spring Harb Perspect Med</source><volume>3</volume><issue>a010306</issue><year>2013</year><pub-id pub-id-type="pmid">23545571</pub-id><pub-id pub-id-type="doi">10.1101/cshperspect.a010306</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-WASJ-7-3-00324" position="float">
<label>Figure 1</label>
<caption><p>Antimicrobial activity of <italic>R. frangula</italic> against <italic>A. baumannii</italic>. (A) The antimicrobial activity of <italic>R. frangula</italic> extract is demonstrated by a zone of inhibition measuring 16 mm in diameter against <italic>A. baumannii</italic>. (B) DMSO serves as the control, showing no inhibition zone. <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g00.tif"/>
</fig>
<fig id="f2-WASJ-7-3-00324" position="float">
<label>Figure 2</label>
<caption><p>(A) Control sample. (B) Heart tissue sample with infiltration of <italic>A. baumannii</italic> (yellow arrow), exhibiting chronic inflammatory infiltrate (x40 total magnification). (C) Degeneration of cardiac muscles (yellow arrow) (x40 total magnification). (D) Cardiac tissue treated with 5 mg/ml <italic>R. frangula</italic> extract exhibited a gradual decrease in bacterial load and inflammatory infiltrate (red arrow) (x40 total magnification). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g01.tif"/>
</fig>
<fig id="f3-WASJ-7-3-00324" position="float">
<label>Figure 3</label>
<caption><p>(A) Control sample. (B) Lung tissue with inflammatory infiltrate (yellow arrow). (C) Diffuse alveolar septal thickening post infiltration of <italic>A. baumannii</italic> with degeneration of bronchial epithelium (green arrow) (x40 total magnification). (D) Lung tissue treated with 5 mg/ml <italic>R. frangula</italic> extract exhibited a decreased bacterial load and inflammatory infiltrate (red arrow) (x40 total magnification). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula</italic>.</p></caption>
<graphic xlink:href="wasj-07-03-00324-g02.tif"/>
</fig>
<fig id="f4-WASJ-7-3-00324" position="float">
<label>Figure 4</label>
<caption><p>(A) Hepatocytes exhibiting vacuolar degeneration with infiltration of <italic>A. baumannii</italic> (yellow arrow) (x40 total magnification). (B) Liver tissue treated with 5 mg/ml <italic>R. frangula</italic> extract exhibited a gradual decrease in bacterial load (indicated by red arrows) under x40 total magnification. <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g03.tif"/>
</fig>
<fig id="f5-WASJ-7-3-00324" position="float">
<label>Figure 5</label>
<caption><p>(A) Spleen exhibiting a generalized area of degeneration of germinal center with infiltration of <italic>A. baumannii</italic> (yellow arrow) (x10 magnification). (B) Bacterial load with dense inflammatory infiltrate (green arrow) (x40 total magnification). (C) Decreased bacterial load post-treatment with 5 mg/ml <italic>R. frangula</italic> extract (red arrow) (x40 total magnification). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g04.tif"/>
</fig>
<fig id="f6-WASJ-7-3-00324" position="float">
<label>Figure 6</label>
<caption><p>(A) Spleen exhibiting areas of degeneration of kidney tubules and areas of Bowman's capsule showing <italic>A. baumannii</italic> with chronic inflammatory infiltrate (yellow arrow) (x10 total magnification). (B) Areas exhibiting vacuolar degeneration of kidney and Bowman's capsule along with decreased bacterial load post-treatment with 5 mg/ml of <italic>R. frangula</italic> extract (red arrow) (x40 total magnification). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g05.tif"/>
</fig>
<fig id="f7-WASJ-7-3-00324" position="float">
<label>Figure 7</label>
<caption><p>Crystal violet biofilm inhibition assay. Graphical representation: 67.26, 58.22 and 47.37% of biofilm inhibition in <italic>A. baumannii</italic> when treated with 2.5, 1.25 and 0.625 mg/ml of <italic>R. frangula</italic> extract, respectively. Statistical analysis was performed using one-way ANOVA followed by Tukey's Honestly Significant Difference (HSD) test (<sup>*</sup>P&lt;0.05, significant difference compared to the untreated control). The x value refers to the concentration of <italic>R. frangula</italic> extract in mg/ml (presented on the x-axis), and the y value refers to the % of biofilm production (presented on the y-axis). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g06.tif"/>
</fig>
<fig id="f8-WASJ-7-3-00324" position="float">
<label>Figure 8</label>
<caption><p>Analysis of the growth curve. <italic>A. baumannii</italic> grown both in the absence (control) and with 2.5 mg/ml <italic>R. frangula</italic> extract. <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></caption>
<graphic xlink:href="wasj-07-03-00324-g07.tif"/>
</fig>
<table-wrap id="tI-WASJ-7-3-00324" position="float">
<label>Table I</label>
<caption><p>Antibiogram of <italic>Acinetobacter baumannii</italic> against several antibiotics.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Sample no.</th>
<th align="center" valign="middle">Antibiotics</th>
<th align="center" valign="middle"><italic>Acinetobacter baumannii</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="left" valign="middle">Tetracycline</td>
<td align="center" valign="middle">10±0.8</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="left" valign="middle">PIT</td>
<td align="center" valign="middle">11±0.8</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="left" valign="middle">Cefixime</td>
<td align="center" valign="middle">R</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="left" valign="middle">Imipenem</td>
<td align="center" valign="middle">R</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="left" valign="middle">Ceftriaxone</td>
<td align="center" valign="middle">R</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="left" valign="middle">Cefotaxime</td>
<td align="center" valign="middle">R</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="left" valign="middle">Meropenem</td>
<td align="center" valign="middle">R</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>R, resistant.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-WASJ-7-3-00324" position="float">
<label>Table II</label>
<caption><p>Minimum inhibitory concentration of <italic>R. frangula</italic> extract for the inhibition of <italic>A. baumannii</italic> growth (final concentration of 5 mg/ml).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Sample no.</th>
<th align="center" valign="middle">Two-fold dilution concentration (mg/ml)</th>
<th align="center" valign="middle">Growth measured<sup><xref rid="tfna-WASJ-7-3-00324" ref-type="table-fn">a</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">10</td>
<td align="center" valign="middle">-</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">5</td>
<td align="center" valign="middle">-</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">2.5</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">1.25</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">0.62</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">0.312</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">0.156</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="center" valign="middle">0.078</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="center" valign="middle">0.039</td>
<td align="center" valign="middle">+</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="center" valign="middle">0.019</td>
<td align="center" valign="middle">+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfna-WASJ-7-3-00324"><p><sup>a</sup>The growth measured refers to the presence (+) or absence (-) of visible growth in the microbial culture following exposure to the respective 2-fold dilution concentrations (mg/ml). <italic>A. baumannii</italic>, strain of <italic>Acinetobacter baumannii</italic>; <italic>R. frangula</italic>, <italic>Rhamnus frangula.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
